The Combined Effect of Chronic Cannabis Use and Subconcussive Head Impacts on Brain Health
The Effect of Chronic Cannabis Use on Neural Response to Acute Subconcussive Head Impacts
1 other identifier
interventional
70
1 country
1
Brief Summary
The purpose of this pilot study is to better understand the effects of chronic cannabis (THC) use on the neural responses to subconcussive head impacts, as a form of repetitive soccer headings. The study is designed to identify the physiological changes of cannabis using cohort (THC) and compare it to a nonusing cohort in order to see if the responses to 20 controlled bouts of soccer headings are exacerbated by the chronic cannabis use, diminished to less of a response, or unchanged, through an array of neurologic measures, including cognitive function, ocolar-motor function, autonomic function, and blood biomarkers. The hypothesis is that repetitive subconcussive head impacts will impair cognitive function in worse memory, attention span, and visual and verbal problem solving; this impairment will be greater in the chronic cannabis use groups than non-using group. The blood and salivary biomarkers neurofilament light (NFL) and glial fibrillary acidic protein (GFAP) will be measured in plasma, with the hypothesis that repetitive subconcussive head impacts will significantly increase plasma NFL and GFAP level at 24 hours-post heading and decrease by 72 hours-post heading, while remaining undetectable at 2 hours-post heading; the chronic cannabis use groups will see more severe effects on ocular-motor function than the non-using group. The study aims to determine the differences in acute effects of subconcussive head impacts on eye movement, attention, and language function between chronic cannabis use subjects and non-using subjects by evaluating ocular-motor function with near point of convergence and King-Devick tests. The hypothesis is that repetitive subconcussive head impacts will significantly increase impairments of eye movements, attention, and language function, as well as near point of convergence; the chronic cannabis use groups will see more severe effects on hampered ocular-motor function than the non-using group. Lastly, there is a cold pressor test to assess autonomic nerve function, with the hypothesis that repetitive subconcussive head impacts will decrease autonomic nerve function in chronic cannabis use patients to a greater degree than non-using subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2020
CompletedFirst Submitted
Initial submission to the registry
November 18, 2020
CompletedFirst Posted
Study publicly available on registry
November 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMarch 2, 2023
February 1, 2023
11 months
November 18, 2020
February 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Acute change in brain-derived blood and saliva biomarkers from pre to 24 hour post-heading
Blood samples will be collected and centrifuged at 1500 x g for ten minutes at 4 degree celsius. Serum and saliva samples will be aliquoted and stored at -80 degree celsius until analysis. Serum and saliva samples will be assayed for S100B, neurofilament-light (NfL), glial fibrillary acidic protein (GFAP), and tau, and UCH-L1. All expression levels in pg/mL.
Blood samples will be collected at pre- and 24 hour post-heading
Acute change in brain-derived blood and saliva biomarkers from pre to 2 hour post-heading
Blood samples will be collected and centrifuged at 1500 x g for ten minutes at 4 degree celsius. Serum and saliva samples will be aliquoted and stored at -80 degree celsius until analysis. Serum and saliva samples will be assayed for S100B, neurofilament-light (NfL), glial fibrillary acidic protein (GFAP), and tau, and UCH-L1. All expression levels in pg/mL.
Blood and saliva samples will be collected at pre- and 2 hour post-heading
Acute change in neurocognitive function from pre to 2 hour post-heading
Participants will complete a computerized neurocognitive assessment (Immediate Post-Concussion Assessment and Cognitive Testing).
Neurocognitive function will be assessed at pre- and 2 hour post-heading
Acute change in neurocognitive function from pre to 24 hour post-heading
Participants will complete a computerized neurocognitive assessment (Immediate Post-Concussion Assessment and Cognitive Testing).
Neurocognitive function will be assessed at pre- and 24 hour post-heading
Acute change in ocular-motor function from pre to 2 hour post-heading
Participants will undergo 2 ocular-motor assessments: 1) near-point of convergence and 2) King-Devick Test--a brief assessment of saccadic eye movements, attention, and visual and language processing.
Ocular-motor function will be assessed at pre- and 2 hour post-heading
Acute change in ocular-motor function from pre to 24 hour post-heading
Participants will undergo 2 ocular-motor assessments: 1) near-point of convergence and 2) King-Devick Test--a brief assessment of saccadic eye movements, attention, and visual and language processing.
Ocular-motor function will be assessed at pre- and 24 hour post-heading
Secondary Outcomes (6)
Acute change in brain-derived blood and saliva biomarkers from pre to 72 hour post-heading
Blood and saliva samples will be collected at pre- and 72 hour post-heading
Acute change in neurocognitive function from pre to 72 hour post-heading
Neurocognitive function will be assessed at pre- and 72 hour post-heading
Acute change in ocular-motor function from pre to 72 hour post-heading
Ocular-motor function will be assessed at pre- and 72 hour post-heading
Acute change in autonomic nerve function from pre to 2 hour post-heading
Autonomic response will be assessed at pre- and 2 hour post-heading
Acute change in autonomic nerve function from pre to 24 hour post-heading
Autonomic response will be assessed at pre- and 24 hour post-heading
- +1 more secondary outcomes
Study Arms (2)
Chronic cannabis use and subconcussive head impacts
EXPERIMENTALGroup: Chronic cannabis users Criteria: self-reported chronic THC use (average use once per week but not dependent). Urine cannabis test must show positive. Device: Soccer Heading Soccer Heading: Subjects stood approximately 40 feet away from a JUGS soccer ball launcher and participated in 20 consecutive soccer headings, separated by one minute intervals.
Non-cannabis use and subconcussive head impacts
ACTIVE COMPARATORGroup: Non cannabis users Criteria: self-reported none THC use. Urine cannabis test must show negative. Device: Soccer Heading Soccer Heading: Subjects stood approximately 40 feet away from a JUGS soccer ball launcher and participated in 20 consecutive soccer headings, separated by one minute intervals.
Interventions
A standardized and reliable soccer heading protocol will be used for the experiment. A triaxial accelerometer embedded in a head-band pocket and positioned directly below the external occipital protuberance (inion) to monitor linear and rotational head accelerations. A JUGS soccer machine will be used to simulate a soccer throw-in with a standardized ball speed of 25mph. The ball speed is similar to when soccer players make a long throw-in from the sideline to mid-field. Soccer players frequently perform this maneuver during practice and games. Subjects will stand approximately 40ft away from the machine to perform the heading. Participants perform 20 standing headers with 1 header per 30 seconds. The subjects will be instructed to direct the ball back toward the JUGS soccer machine in the air.
Eligibility Criteria
You may qualify if:
- For Chronic THC User Group
- being between 18 to 26 years of age
- self-reported chronic THC use (average use once per week but not dependent)3) at least 3 years of soccer heading experience.
- For Non-User Cohort
- being between 18 to 26 years of age
- self-reported non cannabis use in the past 6 months
- at least 3 years of soccer heading experience
You may not qualify if:
- any head, neck, or face injury in the 1 year prior to the study (e.g., concussion, eye injury);
- history of vestibular, ocular, or vision dysfunction (e.g., macular degeneration)
- currently taking any medications affecting balance (e.g., antibiotics)
- pregnancy
- HIV
- any neurological disorders (e.g., seizure disorders, closed head injuries with loss of consciousness greater than 15 minutes, CNS neoplasm, spinal cord injury/surgery, history of stroke)
- hypertension, cardiac arrhythmia, or pulmonary disease
- lower extremity injury that would prohibit performing soccer headings
- metal implants in the head
- used cannabis within the last 72 hours (verified by saliva cannabis test before intervention)
- slept less than 4 hours before the 1st and 2nd test day (verified by screening questionnaire)
- drank any alcoholic drinks or used recreational drugs 72 hours before the 1st test day and during the study period.
- drank more than 3 cups of coffee before any test sessions
- glasses are prohibited (contact lenses are okay) for safety purpose for the heading intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University School of Public Health
Bloomington, Indiana, 47405, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Dr. Kawata (PI) will only know subjects' group assignment and ensure blinded experiment and data processing. They will assign participants into two groups, chronic cannabis users and non-users. Group assignment will be based on self-reported cannabis use history and confirmed on 1st day of the study, with a saliva test ensuring no recent (24h-prior) use and a urine test to confirm history of chronic cannabis use or no use. Under the strict supervision of Dr. Kawata, experienced research assistants will perform soccer heading protocol, blood draws, neurocognitive and ocular-motor testing. Statistician will be blinded from group assignment. These processes will ensure single blind method
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 18, 2020
First Posted
November 24, 2020
Study Start
October 30, 2020
Primary Completion
October 1, 2021
Study Completion
December 1, 2021
Last Updated
March 2, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share
All study data will be included in publications.